Journal
MOLECULES
Volume 25, Issue 3, Pages -Publisher
MDPI
DOI: 10.3390/molecules25030646
Keywords
beta-amyloid; Alzheimer's disease; beta-amyloid precursor protein; alpha-secretase; 7-deoxy-trans-dihydronarciclasine; Lycoris chejuensis
Funding
- Bio-Synergy Research Project - Ministry of Science, ICT, and Future Planning through the National Research Foundation, Republic of Korea [NRF-2012M3A9C4048793]
- Bio & Medical Technology Development Program - Ministry of Science, ICT, and Future Planning through the National Research Foundation, Republic of Korea [NRF-2015M3A9A5030735]
- National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2016R1D1A1A09919505]
- National Research Foundation of Korea [2016R1D1A1A09919505] Funding Source: Korea Institute of Science & Technology Information (KISTI), National Science & Technology Information Service (NTIS)
Ask authors/readers for more resources
Accumulation of beta-amyloid (A beta) in the brain has been implicated in the pathology of Alzheimer's disease (AD). A beta is produced from the A beta precursor protein (APP) through the amyloidogenic pathway by beta-, and gamma-secretase. Alternatively, APP can be cleaved by alpha-, and gamma-secretase, precluding the production of A beta. Thus, stimulating alpha-secretase mediated APP processing is considered a therapeutic option not only for decreasing A beta production but for increasing neuroprotective sAPP alpha. We have previously reported that 7-deoxy-trans-dihydronarciclasine (E144), the active component of Lycoris chejuensis, decreases A beta production by attenuating APP level, and retarding APP maturation. It can also improve cognitive function in the AD model mouse. In this study, we further analyzed the activating effect of E144 on alpha-secretase. Treatment of E144 increased sAPP alpha, but decreased beta-secretase products from HeLa cells stably transfected with APP. E144 directly activated ADAM10 and ADAM17 in a substrate-specific manner both in cell-based and in cell-free assays. The Lineweaver-Burk plot analysis revealed that E144 enhanced the affinities of A Disintegrin and Metalloproteinases (ADAMs) towards the substrate. Consistent with this result, immunoprecipitation analysis showed that interactions of APP with ADAM10 and ADAM17 were increased by E144. Our results indicate that E144 might be a novel agent for AD treatment as a substrate-specific activator of alpha-secretase.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available